Skip to main content

Table 1 Patient characteristics

From: Role of vascular function in predicting arteriovenous fistula outcomes: an observational pilot study

Variable

AVF creation (%), n = 28

No AVF creation (%), n = 24

Entire cohort (n = 52)

Age

72 (62-78)

71 (51-77)

71.5 (59.5 - 77.5)

Gender: Male

21 (75%)

16 (67%)

37 (71%)

Etiology of CKD

Diabetes mellitus

8 (29%)

7 (29%)

15 (29%)

 Hypertension

9 (32%)

5 (21%)

14 (27%)

 Glomerulonephritis

1 (4%)

3 (13%)

4 (8%)

 Obstruction

1 (4%)

2 (8%)

3 (6%)

 Other

9 (32%)

7 (29%)

16 (31%)

 Diabetes mellitus

14 (56%)

14 (58%)

28 (57%)

 Hypertension

27 (100%)

22 (92%)

49 (96%)

 Coronary artery disease, CAD

5 (50%)

5 (45%)

10 (48%)

 Family history of CAD

1 (9%)

2 (18%)

3 (14%)

 Smoker

4 (15%)

3 (13%)

7 (14%)

 Peripheral vascular disease

3 (27%)

3 (27%)

6 (27%)

 Dyslipidemia

8 (62%)

7 (58%)

15 (60%)

eGFR, ml/min/1.7 m2

15 (12-18)

24 (19-31)

17.5 (13 - 25)

Laboratory variables

 Hemoglobin, g/L

121 ± 14

121 ± 16)

121 (15)

 Creatinine, umol/L

343 ± 88

231 ± 57)

291.54 ± 93.54

 Urine microalbumin: creatinine ratio

285 (80-377)

15 (9-111)

95.7 (11.3 - 295)

 Urine Protein: Cr ratio

0.36 (0.10-0.49)

0.03 (0.02-0.14)

0.11 (0.03 - 0.38)

Systolic blood/diastolic pressure left arm

135 (127-153)/78(70-88)

125 (115-148)/75 (68-83)

131.5 (119 - 149)/76 (69 – 85)

Mean arterial pressure

94 (89-106)

93 (84-101)

94 (87.67 - 104)

Beta blocker

8 (29)

3 (12)

11 (21)

Statin

9 (32)

5 (21)

14 (27)